AnidulafunginThird Party Manufacturing in India
Looking to get Anidulafungin manufactured under your brand? Our WHO-GMP certified partner facilities support PCD franchise partners and global export opportunities structured across 25+ countries.
Mechanism of Action
Anidulafungin works by selectively inhibiting the enzyme (1→3)-β-D-glucan synthase, which is responsible for synthesizing (1→3)-β-D-glucan, a critical structural homopolysaccharide in the fungal cell wall. Because this enzyme complex is unique to fungi and absent in mammalian cells, the drug exhibits high specificity. By blocking glucan synthesis, anidulafungin disrupts the integrity of the fungal cell wall, leading to cell wall instability, osmotic lysis, and cell death. It exhibits fungicidal activity against Candida species and fungistatic activity against Aspergillus species.
Unlike older polyene antifungals, anidulafungin does not bind to cholesterol, resulting in a much lower risk of nephrotoxicity. It also avoids significant hepatic metabolism and is instead cleared via slow chemical degradation in the blood, making it exceptionally safe for patients with liver or kidney impairment. In its injectable formulation, it provides reliable systemic coverage for critical care patients suffering from invasive infections.
Therapeutic Uses & Indications
Anidulafungin third party manufacturing in India is a highly specialized segment of our critical care injectables portfolio, providing life-saving antifungal therapies to healthcare providers worldwide.
Therapeutic Uses
Anidulafungin injection is prescribed for the treatment of:
- Invasive Candidiasis (Candidemia): Used as a first-line treatment for bloodstream and deep-tissue infections caused by Candida species.
- Esophageal Candidiasis: Indicated for severe mucosal infections, particularly in immunocompromised patients.
- Invasive Aspergillosis: Used in salvage therapy or combination regimens for refractory Aspergillus infections.
Why Choose a Leading Anidulafungin Manufacturer
Manufacturing sterile lyophilized injectables like anidulafungin requires advanced cleanroom technologies, precise freeze-drying processes, and rigorous quality control. Sourcing from a WHO-GMP certified facility in India ensures that the reconstituted solution meets stringent international pharmacopoeial standards for purity, sterility, and endotoxin levels. Our partner facilities utilize high-speed automated vial filling and lyophilization lines to maintain the highest quality and extend product shelf life.
We offer comprehensive contract manufacturing services for this molecule, and you can view our full range of products in our manufacturing listing. Please contact our team to discuss your specific requirements.
This makes Anidulafungin one of the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.
Dosage Forms We Manufacture
Frequently Asked Questions
What is the minimum order quantity for Anidulafungin?
What dosage forms of Anidulafungin can you manufacture?
Are your manufacturing facilities WHO-GMP certified?
Can you manufacture Anidulafungin for export?
What grade standards do you follow for Anidulafungin?
Get Anidulafungin made under your brand
- WHO-GMP certified facilities
- Quote within 24 hours
- Low MOQ, export ready
+91 9689237122 · replies within hours
Our Manufacturing Capabilities
- WHO-GMP Certified Partner Plants
- 25+ years of pharma industry experience
- PCD Franchise with monopoly rights
- Export support across 25+ countries
- Small batch to commercial scale
- Custom formulation development
Packaging Options
Sterile glass vials (lyophilized powder) with water for injection diluent. Customizable secondary packaging.
Start Manufacturing Anidulafungin Today
Celesta Healthcare provides WHO-GMP certified third-party manufacturing for Anidulafungin across all dosage forms. PCD franchise and export orders welcome.

